Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Antibiotics|February 1, 1996
Discovery of an angiotensin II binding inhibitor from a Cytospora sp. using semi-automated screening proceduresS Stevens-Miles, M A Goetz, G F Bills, et al.
Journal of Applied Microbiology|November 28, 2001
Antimicrobial activity of ergokonin A from Trichoderma longibrachiatumM F Vicente, A Cabello, G Platas, et al.
Systematic and Applied Microbiology|December 7, 2000
The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species biological activity and taxonomy of the producing organismsF Peláez, A Cabello, G Platas, et al.
International Microbiology : the Official Journal of the Spanish Society for Microbiology|January 5, 2002
Arundifungin, a novel antifungal compound produced by fungi: biological activity and taxonomy of the producing organismsM A Cabello, G Platas, J Collado, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2012
Synthesis and biological evaluation of antifungal derivatives of enfumafungin as orally bioavailable inhibitors of β-1,3-glucan synthaseBrian H Heasley, Gregory J Pacofsky, Ahmed Mamai, et al.
Actas Urologicas Espanolas|June 4, 2019
Elastic fusion biopsy versus systematic biopsy for prostate cancer detection: Results of a multicentric study on 1,119 patientsM Oderda, G Marra, S Albisinni, et al.
World Journal of Urology|January 18, 2019
A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomyR Diamand, M Oderda, W Al Hajj Obeid, et al.
Journal of Medicinal Chemistry|July 14, 2020
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-LactamasesThomas F Durand-Réville, Janelle Comita-Prevoir, Jing Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2015
Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafunginJames M Apgar, Robert R Wilkening, Mark L Greenlee, et al.
Nature Microbiology|July 1, 2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumanniiThomas F Durand-Réville, Satenig Guler, Janelle Comita-Prevoir, et al.
Pageof 7